Cargando…
CRISPR Assays for Disease Diagnosis: Progress to and Barriers Remaining for Clinical Applications
Numerous groups have employed the special properties of CRISPR/Cas systems to develop platforms that have broad potential applications for sensitive and specific detection of nucleic acid (NA) targets. However, few of these approaches have progressed to commercial or clinical applications. This revi...
Autores principales: | Huang, Zhen, Lyon, Christopher J., Wang, Jin, Lu, Shuihua, Hu, Tony Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369298/ https://www.ncbi.nlm.nih.gov/pubmed/37162202 http://dx.doi.org/10.1002/advs.202301697 |
Ejemplares similares
-
Outlook for CRISPR-based tuberculosis assays now in their infancy
por: Huang, Zhen, et al.
Publicado: (2023) -
CRISPR-based assays for low-resource settings
por: Huang, Zhen, et al.
Publicado: (2023) -
Ultra-sensitive and high-throughput CRISPR-p owered COVID-19 diagnosis
por: Huang, Zhen, et al.
Publicado: (2020) -
CRISPR-based assay reveals SARS-CoV-2 RNA dynamic changes and redistribution patterns in non-human primate model
por: Huang, Zhen, et al.
Publicado: (2022) -
Gastric Organoids: Progress and Remaining Challenges
por: Pang, Min-Jiao, et al.
Publicado: (2021)